Gastric adenocarcinoma represents one of the most lethal digestive malignancies globally. Timely diagnostic screening enables detection of precancerous dysplastic changes and mucosal neoplasms when complete endoscopic resection remains curatively possible.
Clinical Objectives of Gastric Cancer Screening
- Early identification of intestinal metaplasia, atrophic gastritis, and low-grade or high-grade gastric dysplasia.
- Targeted mucosal visualization with Narrow-Band Imaging (NBI) optical chromoendoscopy.
- Accurate detection and eradication of Helicobacter pylori infection, the foremost primary etiologic risk factor for gastric cancer.
- Screening high-risk cohorts: individuals aged ≥ 40, patients with chronic atrophic gastritis, pernicious anemia, gastric adenomas, or first-degree family history of gastric cancer.
Screening Modalities at Hoa Duc Clinic
Our package incorporates painless high-definition video gastroscopy, targeted mucosal biopsies, rapid urease testing (CLO test), complete blood count, and serum pepsinogen I/II ratio evaluation to deliver unrivaled diagnostic sensitivity.
